Geode Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-670,451
| Closed | -$11.9M | – | 4205 |
|
|
2018
Q3 | $11.9M | Buy |
670,451
+65,708
| +11% | +$1.17M | ﹤0.01% | 1795 |
|
|
2018
Q2 | $8.35M | Buy |
604,743
+219,961
| +57% | +$3.04M | ﹤0.01% | 2015 |
|
|
2018
Q1 | $3.5M | Buy |
384,782
+143,284
| +59% | +$1.3M | ﹤0.01% | 2464 |
|
|
2017
Q4 | $1.03M | Buy |
241,498
+32,603
| +16% | +$139K | ﹤0.01% | 3082 |
|
|
2017
Q3 | $294K | Hold |
208,895
| – | – | ﹤0.01% | 3534 |
|
|
2017
Q2 | $313K | Sell |
208,895
-64,862
| -24% | -$97.2K | ﹤0.01% | 3526 |
|
|
2017
Q1 | $703K | Buy |
273,757
+19,138
| +8% | +$49.1K | ﹤0.01% | 3175 |
|
|
2016
Q4 | $649K | Buy |
254,619
+8,754
| +4% | +$22.3K | ﹤0.01% | 3177 |
|
|
2016
Q3 | $759K | Buy |
245,865
+3,050
| +1% | +$9.42K | ﹤0.01% | 3084 |
|
|
2016
Q2 | $779K | Sell |
242,815
-2,862
| -1% | -$9.18K | ﹤0.01% | 3014 |
|
|
2016
Q1 | $761 | Buy |
245,677
+6,022
| +3% | +$19 | ﹤0.01% | 3021 |
|
|
2015
Q4 | $961K | Buy |
239,655
+3,674
| +2% | +$14.7K | ﹤0.01% | 2930 |
|
|
2015
Q3 | $1.08M | Buy |
235,981
+3,042
| +1% | +$13.9K | ﹤0.01% | 2828 |
|
|
2015
Q2 | $1.21M | Buy |
232,939
+29,480
| +14% | +$153K | ﹤0.01% | 2803 |
|
|
2015
Q1 | $1.27M | Buy |
203,459
+3,807
| +2% | +$23.8K | ﹤0.01% | 2728 |
|
|
2014
Q4 | $1.26M | Buy |
199,652
+255
| +0.1% | +$1.6K | ﹤0.01% | 2708 |
|
|
2014
Q3 | $1.21M | Buy |
199,397
+3,644
| +2% | +$22.1K | ﹤0.01% | 2673 |
|
|
2014
Q2 | $1.29M | Buy |
195,753
+20,144
| +11% | +$133K | ﹤0.01% | 2639 |
|
|
2014
Q1 | $4.18M | Buy |
175,609
+6,302
| +4% | +$150K | ﹤0.01% | 1885 |
|
|
2013
Q4 | $1.81M | Buy |
169,307
+24,802
| +17% | +$265K | ﹤0.01% | 2360 |
|
|
2013
Q3 | $1.93M | Buy |
144,505
+4,225
| +3% | +$56.3K | ﹤0.01% | 2195 |
|
|
2013
Q2 | $1.84M | Buy |
+140,280
| New | +$1.84M | ﹤0.01% | 2090 |
|